Related Experiment Video
Updated: Mar 22, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Predictive features of ligand-specific signaling through the estrogen receptor
Jerome C Nwachukwu1, Sathish Srinivasan1, Yangfan Zheng2
1Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USA.
Abstract:
Some estrogen receptor-α (ERα)-targeted breast cancer therapies such as tamoxifen have tissue-selective or cell-specific activities, while others have similar activities in different cell types. To identify biophysical determinants of cell-specific signaling and breast cancer cell proliferation, we synthesized 241 ERα ligands based on 19 chemical scaffolds, and compared ligand response using quantitative bioassays for canonical ERα activities and X-ray crystallography. Ligands that regulate the dynamics and stability of the coactivator-binding site in the C-terminal ligand-binding domain, called activation function-2 (AF-2), showed similar activity profiles in different cell types. Such ligands induced breast cancer cell proliferation in a manner that was predicted by the canonical recruitment of the coactivators NCOA1/2/3 and induction of the GREB1 proliferative gene. For some ligand series, a single inter-atomic distance in the ligand-binding domain predicted their proliferative effects. In contrast, the N-terminal coactivator-binding site, activation function-1 (AF-1), determined cell-specific signaling induced by ligands that used alternate mechanisms to control cell proliferation. Thus, incorporating systems structural analyses with quantitative chemical biology reveals how ligands can achieve distinct allosteric signaling outcomes through ERα.
Insights
Researchers identified how estrogen receptor-alpha (ERα) ligands control breast cancer cell proliferation. Biophysical properties of ERα
Area of Science:
- Molecular Biology
- Structural Biology
- Pharmacology
Background:
- Estrogen receptor-alpha (ERα)-targeted therapies exhibit variable tissue-specific activities in breast cancer treatment.
- Understanding the biophysical basis of ERα ligand action is crucial for developing effective therapies.
Purpose of the Study:
- To identify the biophysical determinants governing cell-specific ERα signaling and breast cancer cell proliferation.
- To correlate ligand structure with ERα activity profiles and cellular responses.
Main Methods:
- Synthesis of 241 ERα ligands across 19 chemical scaffolds.
- Quantitative bioassays measuring canonical ERα activities.
- X-ray crystallography to determine ligand-ERα complex structures.
- Analysis of coactivator recruitment and gene induction.
Main Results:
- Ligands modulating the activation function-2 (AF-2) coactivator site showed consistent activity across cell types, predicting proliferation via coactivator NCOA1/2/3 and GREB1 induction.
- Specific inter-atomic distances within the ligand-binding domain correlated with proliferative effects for certain ligand series.
- Ligands interacting with the activation function-1 (AF-1) site mediated cell-specific signaling through alternative proliferation mechanisms.
Conclusions:
- Distinct allosteric signaling outcomes of ERα ligands can be achieved through modulation of either the AF-2 or AF-1 coactivator-binding sites.
- Systems structural analysis combined with quantitative chemical biology provides insights into ligand-driven ERα function.
- The study reveals how ligand properties dictate ERα's role in cell-specific breast cancer proliferation.
Related Concept Videos
Signal Transduction: Overview
Typically, signal transduction involves three...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Internal Receptors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...

